Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,581.3
-14.7 (-0.56%)

 

  • STI Straits Times Index
    2,581.3
    -14.7 (-0.56%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,564.6
    -11.8 (-0.75%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,183.0
    -47.7 (-0.19%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,360.1
    39.4 (1.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,289.4
    39.8 (0.17%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,247.7
    8.4 (0.16%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,818.9M
  • Value: 1,195.1M
  • Rise: 145
  • Fall: 205
  • Unch: 458

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.036-
Yinda Infocomm0.035-
Rex Intl0.168-0.013
ChinaKundaTech0.028+0.002
FJ Benjamin^0.020+0.002
Singapore-eDev0.062-0.012
Medtecs Intl1.610+0.050
ThaiBev0.605-
Kitchen Culture0.215-0.105
AnAn Intl0.037-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BIOTRON BIOTRON
Updated on 14 Aug 2020 (End of trading day)
Last (AUD): 0.100 Change: - High: 0.105 Remarks: -
Change (%): - Low: 0.099
Open 0.105 Yesterday's Close 0.1
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,792,871 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.00230 Trailing EPS (AUD) e -0.00488 NAV (AUD) b 0.0120
PE a - Trailing PE f - Price / NAV b 8.3333
Dividend (AUD) d - Cash In Hand (AUD) g 0.0124 Issued & Paid-up Shares c 701,933,000
Dividend Yield (%) d - Price / Cash In Hand g 8.065 Treasury Shares h -
Beta - 75 Daysi 0.467 R-Squared - 75 Days(%)i 0.17 Market Cap (M) 70.193
Beta - 500 Daysi -0.783 R-Squared - 500 Days (%)i 0.29 Enterprise Value (M) 61.581
Piotroski F Score 2 Exchange Code BIT Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 83.24 Free Float (%) 99.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 24 Dec 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BIOTRON ASX 70.193 - - 8.3333 -
Industry Biotechnology ASX 3,556.446 55.799 50.558 13.3822 0.915
Local Peer CSL ASX 126,834.048 47.275 43.784 14.6656 0.950
Local Peer MESOBLAST LTD ASX 2,730.404 - - 3.4259 -
Local Peer POLYNOVO LIMITED ASX 1,480.837 - - 60.3774 -
Local Peer TELIX PHARMACEUTIC ASX 344.094 - - 4.9094 -
Local Peer NEXT SCIENCE LTD ASX 252.350 - - 9.1628 -
Local Peer IMUGENE LIMITED ASX 250.084 - - 3.8356 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 149.950 - - 10.8326 -
Local Peer MEMPHASYS LTD ASX 116.866 - - 11.7424 -
Local Peer ANTEOTECH LIMITED ASX 90.346 - - 28.4211 -
Local Peer IMMUTEP LTD ASX 87.774 - - 3.1304 -
Local Peer GENETIC TECHNOLOGIES ASX 82.617 - - 33.3333 -
Local Peer INVEX THERAPEUTICS LTD NPV ASX 74.402 - - - -
Other Local Peers KAZIA THERAPEUTICS LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), REGENEUS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX)
Global Peer AMGEN INC NASDAQ 140,835.979 17.959 19.295 13.2129 2.436
Global Peer GILEAD SCIENCES INC NASDAQ 85,478.630 15.871 - 4.7417 3.732
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer VERTEX PHARMACEUTICAL NASDAQ 69,583.759 59.129 33.441 9.2541 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 64,993.791 30.718 21.784 7.1758 -
Global Peer ILLUMINA INC NASDAQ 51,615.380 51.512 74.481 11.3117 -
Global Peer BIOGEN INC NASDAQ 45,679.633 7.757 7.707 4.0393 -
Global Peer WUXI BIO HKEx 216,907.105 188.686 188.685 15.1677 -
Global Peer SEATTLE GENETICS INC NASDAQ 27,863.880 - - 15.3598 -
Global Peer MODERNA INC NASDAQ 26,764.836 - - 9.0824 -
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), Lonza (SGX), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GENSCRIPT BIO (HKEx), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), FATE THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), INSMED INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), ALLOVIR INC (NASDAQ), VAXCYTE INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), VERACYTE INC (NASDAQ), ALPHAMAB-B (HKEx), XENCOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), AKEBIA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), NANOSTRING TECHNOLOGIES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), COMPUGEN (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CORTEXYME INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ALECTOR INC (NASDAQ), ARVINAS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ASCENTAGE-B (HKEx), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), NANTKWEST INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), FRONTAGE (HKEx), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PERSONALIS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), KINTOR PHARMA-B (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PRECIGEN INC (NASDAQ), KADMON HLDGS INC (NYSE), AKOUOS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), AGENUS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ARDELYX INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DPHARMA (Bursa), XBIOTECH INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ATHERSYS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINOMAB BIO-B (HKEx), LEE'S PHARM (HKEx), CLOVIS ONCOLOGY INC (NASDAQ), ASCLETIS-B (HKEx), RIGEL PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), IVERIC BIO INC (NASDAQ), KAMADA (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), ESSEX BIO-TECH (HKEx), MANNKIND CORPORATION (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), NANOVIRICIDES INC (NYSE American), TREVENA INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONCERT PHARMACEUTICALS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), PFENEX INC (NYSE American), CALITHERA BIOSCIENCES INC (NASDAQ), IMV INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CABALETTA BIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AFFIMED N V (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHIASMA INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), VERASTEM INC (NASDAQ), NEXTCURE INC (NASDAQ), MEDICINOVA INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IBIO INC (NYSE American), EVOFEM BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), XOMA CORP (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), CONTRAFECT CORP (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), INMUNE BIO INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SESEN BIO INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), CHAMPIONS ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), UNI-BIO GROUP (HKEx), BIONANO GENOMICS INC (NASDAQ), SAVARA INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), AIM IMMUNOTECH INC (NYSE American), DIAMEDICA THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ARAVIVE INC (NASDAQ), VACCINEX INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), RESTORBIO INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), GENOCEA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), RECRO PHARMA INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), COHBAR INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), VASCULAR BIOGENICS LTD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ORAGENICS INC (NYSE American), SEELOS THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), CT ENTERPRISE (HKEx), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), EVOGENE LTD (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), BIOSINO BIO-TEC (HKEx), AETERNA ZENTARIS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), BIOCARDIA INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), Suntar Eco-City (SGX), APTEVO THERAPEUTICS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), REGENT PACIFIC (HKEx), BIO-PATH HOLDINGS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), TRACON PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SENESTECH INC (NASDAQ), HAO WEN HLDGS (HKEx), AURIS MEDICAL HOLDING LTD (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.005
-4.76 %
10 Days -+0.003
+3.09 %
20 Days ---
Medium Term Return 3 Months -+0.010
+11.11 %
6 Months --0.015
-13.04 %
1 Year -+0.025
+33.33 %
Long Term Return 2 Years -+0.083
+488.24 %
3 Years -+0.083
+488.24 %
5 Years -+0.014
+16.28 %
Annualised Return Annualised --
+3.06 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.050 - 0.185 Change From 1 Year Low +0.050 % Change From 1 Year Low (%) +100.00
Change From 1 Year High -0.085 % Change From 1 Year High (%) -45.95
2 Years Range 0.014 - 0.445 Change From 2 Years Low +0.086 % Change From 2 Years Low (%) +614.29
Change From 2 Years High -0.345 % Change From 2 Years High (%) -77.53
5 Years Range 0.014 - 0.445 Change From 5 Years Low +0.086 % Change From 5 Years Low (%) +614.29
Change From 5 Years High -0.345 % Change From 5 Years High (%) -77.53
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Biotron Ltd. is a clinical stage Australian biotechnology company. It engages in developing and commercializing a novel small molecule approach that has the potential to treat a number of serious viral diseases. The company's technology targets viroporin proteins, which are key to enabling the pathogenicity of a number of viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and Respiratory Syncytial Virus. Its proprietary primary bacterial cell-based screening platform enables rapid screening for target viroporin proteins. The company was founded in February 1999 and is headquartered in North Ryde, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Aug 2020 0.105 0.105 0.099 0.100 2,792,871 -
13 Aug 2020 0.105 0.105 0.100 0.100 1,163,433 -
12 Aug 2020 0.100 0.105 0.100 0.105 1,030,935 -
11 Aug 2020 0.105 0.110 0.100 0.100 1,496,377 -
10 Aug 2020 0.110 0.110 0.100 0.105 1,955,296 -
07 Aug 2020 0.105 0.110 0.100 0.105 1,694,584 -
06 Aug 2020 0.105 0.105 0.100 0.100 455,887 -
05 Aug 2020 0.105 0.110 0.105 0.105 3,535,402 -
04 Aug 2020 0.100 0.110 0.100 0.105 3,898,014 -
03 Aug 2020 0.099 0.105 0.099 0.100 2,024,575 -
31 Jul 2020 0.098 0.100 0.096 0.097 964,825 -
30 Jul 2020 0.100 0.102 0.095 0.098 4,212,664 -
29 Jul 2020 0.096 0.105 0.096 0.105 2,938,383 -
28 Jul 2020 0.095 0.098 0.095 0.096 575,997 -
27 Jul 2020 0.100 0.100 0.094 0.097 3,031,870 -
24 Jul 2020 0.098 0.100 0.098 0.099 614,298 -
23 Jul 2020 0.100 0.100 0.095 0.098 3,503,542 -
22 Jul 2020 0.100 0.105 0.100 0.100 2,244,253 -
21 Jul 2020 0.100 0.105 0.100 0.100 2,802,625 -
20 Jul 2020 0.105 0.110 0.105 0.105 1,436,273 -
17 Jul 2020 0.095 0.115 0.095 0.100 3,938,039 -
16 Jul 2020 0.097 0.097 0.093 0.095 976,216 -
Summary
Current 2 Weeks
(03 Aug 2020 to 14 Aug 2020)
0.099 0.110 0.099 0.100 20,047,374 -
Previous 2 Weeks
(20 Jul 2020 to 31 Jul 2020)
0.105 0.110 0.099 0.097 22,324,730 -
4 Weeks from
(19 Jun 2020 to 17 Jul 2020)
0.079 0.110 0.078 0.100 122,864,965 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.